a lakeview with a walking path over the water with a blue and pink sunset
| Firm News

Indiana Government Actions on Covid-19 - Updated 5/19/2020

Today’s update discusses:

  • Indianapolis offers help for safely reopening restaurants and small businesses
  • state’s first case of multi-system inflammatory syndrome
  • new testing sites in Marion County
  • state receives more shipments of remdesivir

ECONOMY

  • Indianapolis Mayor Joe Hogsett has announced steps officials are taking to make it easier for Marion County restaurants and other businesses to open while also adhering to social distancing guidelines. For example, the city is planning to close portions of streets to give restaurants more space for outdoor dining, which may begin on Friday.

HEALTH

  • The Indiana State Department of Health announced the first case of multi-system inflammatory syndrome in an older child at Riley Hospital for Children at IU Health. The syndrome, which is connected to COVID-19, can occur in children weeks after they have had COVID-19 and can lead to serious illness or death. The Department emphasized that parents of children who have had COVID-19 should be aware of the symptoms.

RESOURCES

  • Marion County Public Health Department has announced the closure of two testing sites and the opening of two others. Drive-thru and walk-up testing at Warren Central High School will begin tomorrow and will be available from 6:00 a.m. to 2:00 p.m. on Mondays, Wednesdays, and Fridays. The other new testing site will open at Indianapolis Motor Speedway, starting Tuesday next week, and will operate on Tuesdays and Thursdays from 11:00 a.m. until 7:00 p.m. Similar to many other testing sites, residents will be tested if they show symptoms of COVID-19, are an essential worker, or are at high-risk.
  • As previously updated, Indiana received doses of the drug remdesivir to use at various hospitals to treat COVID-19 patients. This week, Indiana received two more shipments of the drug and is planning to receive weekly shipments in the future. While the drug is still experimental, trials have shown some positive outcomes for some patients.

Attorneys

Jump to Page

HeplerBroom LLC Cookie Preference Center

Your Privacy

When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.

Strictly Necessary Cookies

Always Active

Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.

Functional Cookies

Always Active

Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information.

Form Submissions

Always Active

When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages.

Performance Cookies

Performance cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.

Powered by Firmseek